Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Italy

 

Selling whole genome sequencing to consumers

Javier Echevarria, CEO, Europe and LatAm of Veritas International (VI) has one of the most interesting challenges in marketing - how do you persuade wealthy consumers to spend around $2,000 on predictive whole genome sequencing (WGS)?  He has a broad canvas - his remit is to sell across LatAm, UAE, Europe and Japan.

FREE BLOG Is Acute’s little brother Rehab coming of age?

HBI has just finished a deep dive into the rehabilitation sector. This small, fragmented, poor relative of acute care is often ignored by operators. A perception of low margins and a reluctance among acute hospitals to refer on to rehab cannot be helping. But things are changing, and new markets are opening up.

IPOs no-show as market slows

Two of Europe’s biggest healthcare companies which were widely expected to IPO imminently are now, we hear, ruling out this year. Why the delay – and what does this tell us about the state of a slowing market? HBI speaks to an operator CEO and investment banking sources.

San Donato looks set to IPO

Despite a generally weak hospital IPO market in Europe, Italy's largest hospital operator by revenue, Gruppo San Donato, looks set to list - perhaps prompted by the strong start the country's stock market has made to 2019.

Interview: Michael Sandhu, Remedium RT

After a long career at radiotherapy supplier Varian where he ended as Vice President, Global Market Development, Michael has set up his own consultancy to advise governments, international agencies and the private sector on the development of radiation therapy services in general and the best business models.  HBI asks him where the opportunities are and what they look like. 

Garofalo’s IPO likely to worry Big Three

Family-owned Italian hospital and nursing home operator Garofalo's listing on the Milan Stock exchange fetched a smaller price than market watchers may have expected. What does its multiple mean for the trio of Italian groups waiting in the wings to IPO?

Find Us